Megatas-S 25 Tablet ER
Megatas-S 25 Tablet ER
Mirabegron (25mg) + Solifenacin (5mg)
Mirabet S 25mg/5mg Tablet ER
Macleods Pharmaceuticals Pvt Ltd
Solifenacin 5mg
Pack Size
1 units
Price
Save ₹48
that's 13% off!
About This Medicine
Product description & overview
Megatas-S 25 Tablet ER: A Comprehensive Treatment for Overactive Bladder
Megatas-S 25 Tablet ER is a prescription medication designed to provide long-lasting relief for individuals suffering from overactive bladder (OAB). This unique formulation combines two active ingredients: Mirabegron (25mg) and Solifenacin (5mg).
Mirabegron: This medication acts directly on the bladder muscles to relax them, ultimately aiding in urine storage. Its effectiveness makes it a first-line treatment option for OAB symptoms like urgency and frequent urination.
Solifenacin: This drug relaxes the sphincter muscle at the bladder neck to improve its ability to hold urine. It aids in controlling urinary frequency and reducing incontinence episodes.
Mechanism of Action: By combining Mirabegron and Solifenacin, Megatas-S 25 Tablet ER offers a comprehensive approach to managing OAB symptoms. The medication works throughout the day by gradually releasing both Mirabegron and Solifenacin into the bloodstream, providing extended relief for up to 12 hours with a single dose.
Megatas-S 25 Tablet ER is carefully formulated for effective long-term management of OAB. This medication should be taken exactly as directed by your healthcare provider.
Active composition
Solifenacin 5 mg
+1 more active ingredient
About Solifenacin
Solifenacin is an antimuscarinic agent used to treat overactive bladder symptoms. It works by relaxing bladder muscles and reducing urgency. Solifenacin's clinical significance lies in its ability to improve bladder control. In summary, Solifenacin is beneficial for managing urinary incontinence.
How It Works
Solifenacin antagonizes muscarinic receptors in the bladder, reducing detrusor muscle contractions and increasing bladder capacity.
All Active Ingredients
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Megatas-S 25 Tablet ER during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Megatas-S 25 Tablet ER during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
There is limited information available on the use of Megatas-S 25 Tablet ER in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Megatas-S 25 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Megatas-S 25 Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Megatas-S 25 Tablet ER